A Phase 3 interventional study of hydrocodone / acetaminophen extended release and Placebo in Osteoarthritis, sponsored by Abbott. Completed at 83 sites in United States. Open to participants aged 21 Years to 80 Years. Per ClinicalTrials.gov, last updated 2011-01-25.
Sponsored by Abbott · Phase 3, Interventional, and Treatment
The purpose of this study is to compare the safety and pain-relieving ability of Vicodin CR to placebo in subjects with osteoarthritis (OA) of the hip or knee.
4,398 studies on the registry are indexed under Osteoarthritis; 582 are open to participants now.
This study's enrollment of 873 is above the median of 70 across 3,440 interventional studies indexed under Osteoarthritis.
Browse Osteoarthritis studies →Abbott is the lead sponsor of 350 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Drug: hydrocodone / acetaminophen extended release
Drug: Placebo
2 tablets twice daily
Also known as: ABT-712
2 tablets twice daily
Pain Intensity
Arthritis Pain Intensity measured by a 100mm Visual Analog Scale (VAS)
Time frame: 12 weeks
Pain intensity difference (PID) from baseline to each scheduled evaluation
Time frame: 12 weeks
Western Ontario and McMaster (WOMAC) Osteoarthritis Index total score
Time frame: 12 weeks
SF-36v2 Health Status Survey
Time frame: 12 weeks
This study is completed, as verified in Jan 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Abbott